Table 2 Incidence rate of MASLD after PS matching for all variables.

From: Association between cholecystectomy and the risk of new-onset metabolic dysfunction-associated steatotic liver disease: a risk-stratified cohort study

Variable

 

Number of

subjects

PY

(Person Years)

Number of

incident MASLD

IR

per 1000 PY

HR

(95% CI)

Cholecystectomy

No

13,992

83,633.2

1,704

20.37

1

 

Yes

4,664

16,133.9

482

29.87

1.48(1.34–1.64)

CMRF

< 3

5,673

31,247.8

283

9.06

1

 

≥ 3

12,983

68,519.3

1,903

27.77

3.07(2.71–3.48)

Cholecystectomy & CMRF

Cholecystectomy(No), CMRF(< 3)

4,285

26,318.5

231

8.78

1

 

Cholecystectomy(No), CMRF(≥ 3)

9,707

57,314.7

1,473

25.70

2.94(2.56–3.37)

 

Cholecystectomy(Yes), CMRF(< 3)

1,388

4,929.3

52

10.55

1.22(0.90–1.64)

 

Cholecystectomy(Yes), CMRF(≥ 3)

3,276

11,204.7

430

38.38

4.45(3.79–5.22)

  1. PY, Person-years; IR, Incidence rate; HR, Hazard ratio; CMRF, cardiometabolic risk factor.